论文部分内容阅读
目的确定全身扩散加权(DW)MR成像用于评估骨髓瘤治疗反应的可行性。材料与方法此回顾性单中心研究遵从HIPAA并获当地伦理委员会批准。每名受试者均签
Objective To determine the feasibility of whole body diffusion-weighted (MR) MR imaging for assessing myeloma response to therapy. Materials and Methods This retrospective single-center study complied with HIPAA and was approved by a local ethics committee. Each subject signs